Dana Investment Advisors, Inc. Pfizer Inc Transaction History

Dana Investment Advisors, Inc.

$2.99 Billion
Q3 2024

A detailed history of Dana Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 107,467 shares of PFE stock, worth $2.83 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

107,467

Previous 100,181 7.27%

Holding current value

$2.83 Million

Previous $2.8 Million 10.95%

% of portfolio

0.1%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $201,822 - $228,707	7,286 Added 7.27%	107,467 $3.11 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $221,555 - $259,621	8,771 Added 9.6%	100,181 $2.8 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $22,757 - $26,132	879 Added 0.97%	91,410 $2.54 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $61,457 - $79,826	-2,352 Reduced 2.53%	90,531 $2.61 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $120,369 - $140,700	3,751 Added 4.21%	92,883 $3.08 Million
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $14,520 - $16,799	-402 Reduced 0.45%	89,132 $3.27 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $35,608 - $46,357	-904 Reduced 1.0%	89,534 $3.65 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $75,776 - $98,917	-1,815 Reduced 1.97%	90,438 $4.64 Million
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $1.64 Million - $2 Million	-37,399 Reduced 28.85%	92,253 $4.04 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $722,843 - $857,065	15,535 Added 13.61%	129,652 $6.8 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $2.56 Million - $3.17 Million	-55,928 Reduced 32.89%	114,117 $5.91 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $4.15 Million - $6.15 Million	100,445 Added 144.32%	170,045 $10 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $391,361 - $502,737	-9,971 Reduced 12.53%	69,600 $2.99 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $521,485 - $590,754	14,522 Added 22.32%	79,571 $3.12 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $336,340 - $379,324	10,043 Added 18.26%	65,049 $2.36 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $396,385 - $504,038	11,843 Added 27.44%	55,006 $2.03 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $38,004 - $44,588	1,197 Added 2.85%	43,163 $1.58 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $7,017 - $8,513	-233 Reduced 0.55%	41,966 $1.37 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $435,642 - $622,438	-16,117 Reduced 27.64%	42,199 $1.38 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $96,554 - $109,576	2,933 Added 5.3%	58,316 $2.29 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $53,478 - $69,345	-1,646 Reduced 2.89%	55,383 $1.99 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $12.8 Million - $14.4 Million	-347,025 Reduced 85.89%	57,029 $2.47 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $2.95 Million - $3.24 Million	-78,543 Reduced 16.28%	404,054 $17.2 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $5.2 Million - $5.93 Million	-135,228 Reduced 21.89%	482,597 $21.1 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.04 Million - $1.26 Million	-30,150 Reduced 4.65%	617,825 $27.2 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $1.19 Million - $1.27 Million	36,034 Added 5.89%	647,975 $0
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $85,040 - $98,658	2,665 Added 0.44%	611,941 $21.7 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $11,175 - $11,857	336 Added 0.06%	609,276 $0
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $18.9 Million - $20.8 Million	608,940	608,940 $21.7 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Pfizer Inc Transaction History